sb 203580 has been researched along with razoxane in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (razoxane) | Trials (razoxane) | Recent Studies (post-2010) (razoxane) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 824 | 115 | 56 |
| Protein | Taxonomy | sb 203580 (IC50) | razoxane (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.19 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altieri, P; Ballestrero, A; Barisione, C; Barsotti, A; Brunelli, C; Fabbi, P; Garibaldi, S; Ghigliotti, G; Manca, V; Spallarossa, P | 1 |
1 other study(ies) available for sb 203580 and razoxane
| Article | Year |
|---|---|
Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase.
Topics: Anthracenes; Antibiotics, Antineoplastic; Antioxidants; Blotting, Western; Carbazoles; Carvedilol; Catecholamines; Cell Line; Doxorubicin; Enzyme Activation; Flavonoids; Humans; Imidazoles; Imidazolines; Janus Kinase 1; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; NADPH Oxidases; p38 Mitogen-Activated Protein Kinases; Propanolamines; Protein-Tyrosine Kinases; Pyridines; Razoxane | 2006 |